Polar lipids represented a small fraction of the tear lipid profile, accounting for 1.2% in the morning and 1.0% in the evening. Phosphatidylcholine was the predominant polar lipid in tears. Overall, the investigators reported no significant morning-to-evening differences in relative proportions of individual tear lipid classes.1
Meibum samples showed a similar pattern. Nonpolar lipids comprised 99.4% of meibum lipids in the morning and 99.2% in the evening. Wax esters were again the principal component, representing 73.3% in the morning and 72.8% in the evening, followed by cholesteryl esters at 25.3% and 24.3%, respectively. Triglycerides were higher in evening meibum, increasing from 0.72% to 1.9%.1
Among polar lipids in meibum, diacylglycerols and phosphatidylserine were significantly higher in evening samples (P = .04 and P = .03, respectively). Other measured polar lipids did not differ significantly between time points.1
Clinical context and interpretation
Dry eye disease is characterized by loss of tear film homeostasis, with tear film instability, hyperosmolarity, ocular surface inflammation, damage, and neurosensory abnormalities contributing to symptoms.2 The lipid layer, largely supplied by the meibomian glands, helps support tear film spreading and may reduce evaporation.3,4 Patients frequently report worsening ocular comfort later in the day, particularly with prolonged digital device use or other environmental exposures.5
This study suggests that, at least in healthy young adults, end-of-day ocular surface changes may not be explained by broad shifts in the major nonpolar lipid classes. The statistically significant changes were limited to low-abundance meibum lipid fractions, which the authors described as potential molecular-level modulation rather than a change in the dominant lipid profile.1
Limitations and future research
The study was small and included only 15 healthy participants. The cohort excluded contact lens wearers and individuals with known ocular surface disease, limiting generalizability to patients with dry eye disease, meibomian gland dysfunction, or contact lens discomfort. The authors also noted that subclinical dry eye could not be fully excluded because comprehensive standardized dry eye testing was not performed.1
Sampling was limited to 2 time points, which may miss more complex diurnal patterns. Tear collection always preceded meibum collection, and although a 10-minute washout period was used, residual procedural effects cannot be ruled out. Future studies should include larger and more heterogeneous cohorts, validated symptom questionnaires, clinical tear film assessments, and sampling during periods of active discomfort to clarify whether subtle lipidomic changes correlate with symptoms or disease states.1
References:
Kumar M, Raj A, Vijay AK, Dumpati S, Masoudi S, Willcox M. Diurnal variation of tear and meibum lipids in healthy subjects. Ophthalmic Physiol Opt. Published May 27, 2026. doi:10.1007/s44402-026-00112-5
Perez VL, Chen W, Craig JP, Dogru M, Jones L, Stapleton F, et al. TFOS DEWS III: executive summary. Am J Ophthalmol. 2026;282:135-145. doi:10.1016/j.ajo.2025.09.035
Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347-360. doi:10.1016/j.exer.2003.09.019
Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124:S20-S26. doi:10.1016/j.ophtha.2017.05.031
Wolffsohn JS, Lingham G, Downie LE, et al. TFOS Lifestyle: impact of the digital environment on the ocular surface. Ocul Surf. 2023;28:213-252. doi:10.1016/j.jtos.2023.04.004